Methods of decreasing vascular calcification using IL-1 inhibitors

Details for Australian Patent Application No. 2006304778 (hide)

Owner Amgen Inc.

Inventors Martin, David; Henley III, Charles M.

Agent Wrays

Pub. Number AU-B-2006304778

PCT Pub. Number WO2007/047969

Priority 60/729,305 21.10.05 US

Filing date 20 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 28 April 2011

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047969 Priority application(s): WO2007/047969

28 April 2011 Application Accepted

  Published as AU-B-2006304778

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304783-Rotating optical catheter tip for optical coherence tomography

2006304775-MRI-safe high impedance lead systems and related methods